Browsing by Subject "A61P 31/04"

Now showing items 21-31 of 31

    • Modified lantibiotics and methods of making and using the modified lantibiotics 
      Smith, James L.; Escano, Jerome (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2022-01-18)
      The subject invention pertains to a modified lantibiotic containing an intact cysteine at the C-terminus, particularly, a cysteine that is not decarboxylated and that contains a free carboxyl group. Derivatives of the ...
    • Monoclonal antibodies recognizing a coagulase-negative staphylococcal protein 
      Patti, Joseph M.; Hutchins, Jeff T.; Hall, Andrea; Santos, Linda; Bowden, Maria; Hook, Magnus (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2013-07-02)
      Monoclonal antibodies which can bind to the SdrF protein of Staphylococcus epidermidis are provided which can be useful in the treatment and protection against infection from staphylococcal bacteria such as Staphylococcus ...
    • Multicomponent vaccines 
      Patti, Joseph M.; Foster, Timothy J.; Hook, Magnus (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2010-02-23)
      Multicomponent vaccines are provided which aid in the prevention and treatment of staphylococcal infections and which include certain selected combinations of bacterial binding proteins or fragments thereof, or antibodies ...
    • Multicomponent vaccines 
      Patti, Joseph M.; Foster, Timothy J.; Hook, Magnus (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2004-03-09)
      Multicomponent vaccines are provided which aid in the prevention and treatment of staphylococcal infections and which include certain selected combinations of bacterial binding proteins or fragments thereof, or antibodies ...
    • Multicomponent vaccines 
      Patti, Joseph M.; Foster, Timothy J.; Hook, Magnus (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2011-09-13)
      Multicomponent vaccines are provided which aid in the prevention and treatment of staphylococcal infections and which include certain selected combinations of bacterial binding proteins or fragments thereof, or antibodies ...
    • Polypeptides and polynucleotides from coagulase-negative staphylococci 
      Foster, Timothy J.; Mccrea, Kirk; Hook, Magnus A. O.; Davis, Stacy; Ni Eidhin, Deirdre; Hartford, Orla (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2003-10-21)
      Isolated proteins, designated SdrF, SdrG and SdrH, and their corresponding amino acid and nucleic acid sequences are provided which are useful in the prevention and treatment of infection caused by coagulase-negative ...
    • Polypeptides and polynucleotides from coagulase-negative staphylococci 
      Foster, Timothy J.; Mccrea, Kirk; Hook, Magnus A. O.; Davis, Stacey; Ni Eidhin, Deirdre; Hartford, Orla (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2010-05-04)
      Methods for treating or preventing infections from coagulase-negative staphylococci using proteins and polypeptides from coagulase-negative staphylococcal bacteria such as S. epidermidis, including proteins designated SdrF, ...
    • Proteins and polypeptides from coagulaslase-negative staphylococci 
      Foster, Timothy J.; Mccrea, Kirk; Hook, Magnus A. O.; Davis, Stacy; Nieidhin, Deirdre; Hartford, Orla (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2009-01-06)
      Proteins and polypeptides from coagulase-negative staphylococcal bacteria such as S. epidermidis, including proteins designated SdrF, SdrG and SdrH, and their effective fragments such as their respective A domains, are ...
    • Recombinant vaccine for porcine pleuropneumonia 
      Struck, Douglas K.; Young, Ryland F.; Chang, Yung-Fu (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1998-09-08)
      This invention discloses the DNA sequences coding for the Actinobacillus pleuropneumonia hemolysin(s). It further discloses a method of producing the A. pleuropneumoniae hemolysin(s) from recombinant cells. It also provides ...
    • Variants of the lantibiotic MU1140 and other lantibiotics with improved pharmacological properties and structural features 
      Hillman, Jeffrey D.; Smith, James Leif; Wilson-Stanford, Shawanda R. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-05-08)
      The invention provides improvements of lantibiotics useful for reducing the numbers of microbes or the reproduction of microbes in or on subjects or objects. One embodiment of the invention provides variants of antibiotics ...
    • Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same 
      Faulkner, Olivia B.; Bielke, Lisa; Calhoun, Leona Nicole; Berghman, Luc; Hargis, Billy (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2020-06-16)
      Vaccine compositions including a yeast comprising an immunostimulatory polypeptide and optionally an antigenic polypeptide are provided herein. The immunostimulatory polypeptide and the antigenic polypeptide are expressed ...